HOPE 2020: Submission and registration are open !

The second edition of the "pHysiopathology of Parkinson's DisEase" (HOPE) conference will be held from 29 to 31 January 2020 at ICM in Paris.

Following the success of the first edition and the very stimulating feedback from participants regarding the latest scientific advances and the integration of basic research into clinical research, we are pleased to invite you to take part in this second edition.

The topics will cover the epigenetic and genetic determinants of Parkinson's disease, their molecular mechanisms and their modelling, in order to better understand the pathophysiology of Parkinson's disease and open pre-clinical, clinical and imaging perspectives.

In addition we propose a workshop the first day on two topics that will be discussed later on during the congress

1) Cellular modelling using microfluidic and stem cell technologies

2) Available imaging tools for cellular models and to humans


Submission and registrations are available on the conference website:

Submission deadline: December 1st, 2019

Registration deadline: January 12, 2020

If you would like to contribute to the organization of this event, we are happily welcoming sponsorship:

Webinar series on Quality and Reproducibility issues

EATRIS is running a series of webinars in the fall of this year, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). These webinars are developed in close collaboration with other Research Infrastructures (EU-OPENSCREEN, INFRAFRONTIER, BBMRI, ECRIN) and initiatives such as Translation Together.

The webinars will be brought to you by experts in the field and include an audience Q&A session during which attendees can ask questions at the end of the lecture. All webinars will be recorded and available for later viewing.

For more information and registration:


EATRIS-Plus project funded by the European Commission

NeurATRIS is pleased to announce that the ‘EATRIS-Plus’ proposal has been funded by the European Commission under the INFRADEV-3 call, which concerns the development and long sustainability of new pan-European research infrastructures. 

NeurATRIS, as EATRIS French node, is one of 19 partners in the four-year project. The project aims to build capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS as one of Europe’s key research infrastructures.

Title of proposal: EATRIS-Plus – Consolidating the capacities of EATRIS-ERIC for personalised medicine

Start date: 2020 (precise date to be confirmed)

Duration: 48 months


EATRIS annual report 2018 is available

EATRIS is happy to present the Annual Report for 2018, the fifth year of active operations for EATRIS ERIC. You will learn about the year’s highlights and notable milestones, presented in a more personal format, told by the passionate advocates of Translational Medicine in EATRIS.